Literature DB >> 2682573

Niemann-Pick disease.

M Elleder1.   

Abstract

Results of the investigation carried out during this decade brought unambigous evidence of biochemical heterogeneity inside the complex of Niemann-Pick disease according to which two entirely different metabolic disorders can be recognized. 1. Niemann-Pick sphingomyelinosis, a clear-cut enzymopathy, the pivotal lesion of which is the deficiency of lysosomal spingomyelinase leading to widespread lysosomal deposition of sphingomyelin liquid crystals. Two main allelic variants are known. The first one, neuronopathic (former type A) known as infantile with rapid course, may also manifest considerably prolonged course or an atypical course with predominantly visceral symptomatology. Patients with the second, visceral, variant (former type B), display mainly slow clinical course and often reach adulthood. With rare exceptions the neuronopathic variant can be biochemically recognized from the visceral one by much lower values of the in vivo sphingomyelin degradation test in the former. 2. The rest of the complex comprising types C-D differs substantially from the sphingomyelinase deficiency group by the remarkable heterogeneity in the lysosomal stored lipid pattern given by differences among the affected cell populations. Sphingomyelin storage could be proved histochemically solely in the histiocytic population together with cholesterol, neutral glycosphingolipids and lysobisphosphatidic acid, whereas the brain neurons displayed only neutral glycosphingolipid storage. There is an increasing evidence of the crucial biochemical lesion in this group being an altered intracellular traffic of exogenously derived cholesterol caused probably by its deficient translocation from lysosomes to other intracellular membrane sites. This leads to decreased cholesterol esterification rate which is the basis of the newly developed diagnostic test. Inconstant depression of sphingomyelinase activity is considered to be a secondary phenomenon. The so-called lactosylceramidosis is a rare variant pertinent to this group. The biochemical nature of type E still awaits clarification. Both groups of Niemann-Pick disease display clinical and especially histochemical features which allows to establish diagnosis in a highly efficient way already at the clinicopathological level.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2682573     DOI: 10.1016/S0344-0338(89)80006-8

Source DB:  PubMed          Journal:  Pathol Res Pract        ISSN: 0344-0338            Impact factor:   3.250


  12 in total

Review 1.  Lipid changes in Niemann-Pick disease type C brain: personal experience and review of the literature.

Authors:  M T Vanier
Journal:  Neurochem Res       Date:  1999-04       Impact factor: 3.996

2.  Subclinical course of cholesterol ester storage disease (CESD) diagnosed in adulthood. Report on two cases with remarks on the nature of the liver storage process.

Authors:  M Elleder; J Ledvinová; P Cieslar; R Kuhn
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1990

3.  Deposition of lipopigment--a new feature of human splenic sinus endothelium (SSE). Ultrastructural and histochemical study.

Authors:  M Elleder
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1990

4.  Erythrophagocytosis by cultured skin fibroblasts from patients with hereditary metabolic disorders.

Authors:  M Elleder; E Holecková; V Mandys
Journal:  Experientia       Date:  1993-01-15

5.  Nerve biopsy findings in Niemann-Pick type II (NPC)

Authors:  A F Hahn; J J Gilbert; C Kwarciak; J Gillett; C F Bolton; C A Rupar; J W Callahan
Journal:  Acta Neuropathol       Date:  1994       Impact factor: 17.088

Review 6.  Imaging of macrophage-related lung diseases.

Authors:  Katharina Marten; David M Hansell
Journal:  Eur Radiol       Date:  2005-01-05       Impact factor: 5.315

7.  Glucosylceramide transfer from lysosomes--the missing link in molecular pathology of glucosylceramidase deficiency: a hypothesis based on existing data.

Authors:  M Elleder
Journal:  J Inherit Metab Dis       Date:  2006-11-02       Impact factor: 4.982

8.  Promising CNS-directed enzyme replacement therapy for lysosomal storage diseases.

Authors:  Shannon L Macauley; Mark S Sands
Journal:  Exp Neurol       Date:  2009-04-08       Impact factor: 5.330

Review 9.  Secondary lipid accumulation in lysosomal disease.

Authors:  Steven U Walkley; Marie T Vanier
Journal:  Biochim Biophys Acta       Date:  2008-12-09

10.  Progressive liver failure in a patient with adult Niemann-Pick disease associated with generalized AL amyloidosis.

Authors:  H Zhou; R P Linke; H E Schaefer; W Möbius; U Pfeifer
Journal:  Virchows Arch       Date:  1995       Impact factor: 4.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.